Last 12 months
Inside the activity.
2 purchase rows · 26 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 2 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 1, 2026 17:19 UTC |
MORTIMER IANDirector · PRESIDENT & CEO
|
PurchaseCommon Shares | 30,000 | $37.38 | $1,121,400.00 |
DisclosureSEC source: 0001193125-26-409999 · ownership.xml · nonDerivative · entry 1 MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,923 Read SEC document |
| September 30, 2026 Filed Oct 1, 2026 17:20 UTC |
Kelly Thomas PatrickChief Financial Officer
|
PurchaseCommon Shares | 15,000 | $37.32 | $559,740.00 |
DisclosureSEC source: 0001193125-26-410001 · ownership.xml · nonDerivative · entry 1 Kelly Thomas Patrick · CIK 0001410514 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Read SEC document |
| September 01, 2026 Filed Sep 4, 2026 00:26 UTC |
Svoronos DawnDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,144 | $0.00 Strike: $8.15 | $0.00 |
DisclosureSEC source: 0001193125-26-382412 · ownership.xml · derivative · entry 2 Svoronos Dawn · CIK 0001574579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 5,144 shares Expires 2026-09-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| September 01, 2026 Filed Sep 4, 2026 00:26 UTC |
Svoronos DawnDirector
|
Exercise / conversionCommon Shares | 5,144 | $8.15 | $41,923.60 |
DisclosureSEC source: 0001193125-26-382412 · ownership.xml · nonDerivative · entry 1 Svoronos Dawn · CIK 0001574579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,373 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 28, 2026 Filed Sep 1, 2026 01:59 UTC |
KENNEY CHRISTOPHER JOHNChief Medical Officer
|
SaleCommon Shares | 700 | $60.98 | $42,683.62 |
DisclosureSEC source: 0001193125-26-377309 · ownership.xml · nonDerivative · entry 2 KENNEY CHRISTOPHER JOHN · CIK 0001880129 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026. F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $60.81 to $61.12, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. F4 · balance_after: The number of shares beneficially owned following the reported transactions reflects an upward adjustment of one share from the reporting person's previous Form 4 filed on March 13, 2026, based on updated tax withholding calculations for the transactions described on the previously filed Form 4. Read SEC document |
| August 28, 2026 Filed Sep 1, 2026 01:59 UTC |
KENNEY CHRISTOPHER JOHNChief Medical Officer
|
SaleCommon Shares | 6,368 | $60.17 | $383,145.37 |
DisclosureSEC source: 0001193125-26-377309 · ownership.xml · nonDerivative · entry 1 KENNEY CHRISTOPHER JOHN · CIK 0001880129 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 702 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026. F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $59.79 to $60.68, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| August 11, 2026 Filed Aug 13, 2026 20:33 UTC |
GANNON STEVENDirector
|
SaleCommon Shares | 10,000 | $64.06 | $640,550.00 |
DisclosureSEC source: 0001193125-26-349351 · ownership.xml · nonDerivative · entry 1 GANNON STEVEN · CIK 0001643085 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,870 F1 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $64.0517 to $64.078, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 01:19 UTC |
PATOU GARYDirector
|
SaleCommon Shares | 1,322 | $53.14 | $70,251.08 |
DisclosureSEC source: 0001193125-26-262672 · ownership.xml · nonDerivative · entry 1 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,896 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the reporting person on August 17, 2025, solely to satisfy income tax obligations related to the vesting of RSUs granted on June 5, 2025. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 01:19 UTC |
Cannon GillianDirector
|
SaleCommon Shares | 1,190 | $53.14 | $63,236.60 |
DisclosureSEC source: 0001193125-26-262671 · ownership.xml · nonDerivative · entry 1 Cannon Gillian · CIK 0001833910 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,455 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the reporting person on August 15, 2025, solely to satisfy income tax obligations related to the vesting of RSUs granted on June 5, 2025. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 01:04 UTC |
Gover Justin D.Director
|
GrantRestricted Share Units · Derivative | 1,593 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-256124 · ownership.xml · derivative · entry 4 Gover Justin D. · CIK 0001754129 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,593 Underlying: Common Shares · 1,593 shares Expires not disclosed F3 · derivative.exercise_date: Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. F3 · derivative.expiration_date: Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 01:04 UTC |
Gover Justin D.Director
|
GrantShare Option (Right to Buy) · Derivative | 10,507 | $0.00 Strike: $53.46 | $0.00 |
DisclosureSEC source: 0001193125-26-256124 · ownership.xml · derivative · entry 3 Gover Justin D. · CIK 0001754129 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,507 Underlying: Common Shares · 10,507 shares Expires 2036-06-02 F2 · derivative.exercise_date: Vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 01:04 UTC |
GANNON STEVENDirector
|
GrantRestricted Share Units · Derivative | 1,593 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-256121 · ownership.xml · derivative · entry 5 GANNON STEVEN · CIK 0001643085 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,593 Underlying: Common Shares · 1,593 shares Expires not disclosed F5 · derivative.exercise_date: Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. F5 · derivative.expiration_date: Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 01:04 UTC |
GANNON STEVENDirector
|
GrantShare Option (Right to Buy) · Derivative | 10,507 | $0.00 Strike: $53.46 | $0.00 |
DisclosureSEC source: 0001193125-26-256121 · ownership.xml · derivative · entry 4 GANNON STEVEN · CIK 0001643085 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,507 Underlying: Common Shares · 10,507 shares Expires 2036-06-02 F4 · derivative.exercise_date: Vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 01:04 UTC |
PATOU GARYDirector
|
GrantRestricted Share Units · Derivative | 1,593 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-256126 · ownership.xml · derivative · entry 5 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,593 Underlying: Common Shares · 1,593 shares Expires not disclosed F4 · derivative.exercise_date: Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. F4 · derivative.expiration_date: Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 01:04 UTC |
PATOU GARYDirector
|
GrantShare Option (Right to Buy) · Derivative | 10,507 | $0.00 Strike: $53.46 | $0.00 |
DisclosureSEC source: 0001193125-26-256126 · ownership.xml · derivative · entry 4 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,507 Underlying: Common Shares · 10,507 shares Expires 2036-06-02 F3 · derivative.exercise_date: Vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 01:04 UTC |
Machado PatrickDirector
|
GrantRestricted Share Units · Derivative | 1,593 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-256125 · ownership.xml · derivative · entry 4 Machado Patrick · CIK 0001311210 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,593 Underlying: Common Shares · 1,593 shares Expires not disclosed F3 · derivative.exercise_date: Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. F3 · derivative.expiration_date: Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 01:04 UTC |
Machado PatrickDirector
|
GrantShare Option (Right to Buy) · Derivative | 10,507 | $0.00 Strike: $53.46 | $0.00 |
DisclosureSEC source: 0001193125-26-256125 · ownership.xml · derivative · entry 3 Machado Patrick · CIK 0001311210 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,507 Underlying: Common Shares · 10,507 shares Expires 2036-06-02 F2 · derivative.exercise_date: Vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 01:03 UTC |
Svoronos DawnDirector
|
GrantRestricted Share Units · Derivative | 1,593 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-256118 · ownership.xml · derivative · entry 5 Svoronos Dawn · CIK 0001574579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,593 Underlying: Common Shares · 1,593 shares Expires not disclosed F5 · derivative.exercise_date: Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. F5 · derivative.expiration_date: Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 01:03 UTC |
Svoronos DawnDirector
|
GrantShare Option (Right to Buy) · Derivative | 10,507 | $0.00 Strike: $53.46 | $0.00 |
DisclosureSEC source: 0001193125-26-256118 · ownership.xml · derivative · entry 4 Svoronos Dawn · CIK 0001574579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,507 Underlying: Common Shares · 10,507 shares Expires 2036-06-02 F4 · derivative.exercise_date: Vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 01:04 UTC |
GAROFALO ELIZABETH A.Director
|
GrantRestricted Share Units · Derivative | 1,593 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-256122 · ownership.xml · derivative · entry 4 GAROFALO ELIZABETH A. · CIK 0001826361 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,593 Underlying: Common Shares · 1,593 shares Expires not disclosed F3 · derivative.exercise_date: Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. F3 · derivative.expiration_date: Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 01:04 UTC |
GAROFALO ELIZABETH A.Director
|
GrantShare Option (Right to Buy) · Derivative | 10,507 | $0.00 Strike: $53.46 | $0.00 |
DisclosureSEC source: 0001193125-26-256122 · ownership.xml · derivative · entry 3 GAROFALO ELIZABETH A. · CIK 0001826361 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,507 Underlying: Common Shares · 10,507 shares Expires 2036-06-02 F2 · derivative.exercise_date: Vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 01:03 UTC |
Cannon GillianDirector
|
GrantRestricted Share Units · Derivative | 1,593 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-256120 · ownership.xml · derivative · entry 4 Cannon Gillian · CIK 0001833910 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,593 Underlying: Common Shares · 1,593 shares Expires not disclosed F3 · derivative.exercise_date: Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. F3 · derivative.expiration_date: Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 01:03 UTC |
Cannon GillianDirector
|
GrantShare Option (Right to Buy) · Derivative | 10,507 | $0.00 Strike: $53.46 | $0.00 |
DisclosureSEC source: 0001193125-26-256120 · ownership.xml · derivative · entry 3 Cannon Gillian · CIK 0001833910 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,507 Underlying: Common Shares · 10,507 shares Expires 2036-06-02 F2 · derivative.exercise_date: Vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. Read SEC document |
| June 01, 2026 Filed Jun 4, 2026 01:04 UTC |
Gover Justin D.Director
|
Exercise / conversionRestricted Share Units · Derivative | 2,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-256124 · ownership.xml · derivative · entry 2 Gover Justin D. · CIK 0001754129 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 2,645 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. F1 · derivative.exercise_date: Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. F1 · derivative.expiration_date: Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. Read SEC document |
| June 01, 2026 Filed Jun 4, 2026 01:04 UTC |
Gover Justin D.Director
|
Exercise / conversionCommon Shares | 2,645 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-256124 · ownership.xml · nonDerivative · entry 1 Gover Justin D. · CIK 0001754129 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. F1 · price: Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. Read SEC document |
| June 01, 2026 Filed Jun 4, 2026 01:04 UTC |
GANNON STEVENDirector
|
Exercise / conversionRestricted Share Units · Derivative | 2,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-256121 · ownership.xml · derivative · entry 3 GANNON STEVEN · CIK 0001643085 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 2,645 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. F1 · derivative.exercise_date: Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. F1 · derivative.expiration_date: Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. Read SEC document |
| June 01, 2026 Filed Jun 4, 2026 01:04 UTC |
GANNON STEVENDirector
|
Tax withholdingCommon Shares | 1,416 | $53.41 | $75,628.56 |
DisclosureSEC source: 0001193125-26-256121 · ownership.xml · nonDerivative · entry 2 GANNON STEVEN · CIK 0001643085 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,870 F2 · shares: Represents the number of Common Shares withheld by the issuer to satisfy income tax withholding and remittance obligations in connection with the net settlement of the RSUs, and does not represent a sale. F3 · price: Represents the closing price of Common Shares on June 1, 2026 for purposes of net settlement calculations. Read SEC document |
| June 01, 2026 Filed Jun 4, 2026 01:04 UTC |
GANNON STEVENDirector
|
Exercise / conversionCommon Shares | 2,645 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-256121 · ownership.xml · nonDerivative · entry 1 GANNON STEVEN · CIK 0001643085 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. F1 · price: Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. Read SEC document |
| June 01, 2026 Filed Jun 4, 2026 01:04 UTC |
PATOU GARYDirector
|
Exercise / conversionRestricted Share Units · Derivative | 2,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-256126 · ownership.xml · derivative · entry 3 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 2,645 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. F1 · derivative.exercise_date: Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. F1 · derivative.expiration_date: Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. Read SEC document |
| June 01, 2026 Filed Jun 4, 2026 01:04 UTC |
PATOU GARYDirector
|
Exercise / conversionCommon Shares | 2,645 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-256126 · ownership.xml · nonDerivative · entry 1 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,218 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. F1 · price: Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. Read SEC document |
| June 01, 2026 Filed Jun 4, 2026 01:04 UTC |
Machado PatrickDirector
|
Exercise / conversionRestricted Share Units · Derivative | 2,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-256125 · ownership.xml · derivative · entry 2 Machado Patrick · CIK 0001311210 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 2,645 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. F1 · derivative.exercise_date: Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. F1 · derivative.expiration_date: Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. Read SEC document |
| June 01, 2026 Filed Jun 4, 2026 01:04 UTC |
Machado PatrickDirector
|
Exercise / conversionCommon Shares | 2,645 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-256125 · ownership.xml · nonDerivative · entry 1 Machado Patrick · CIK 0001311210 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. F1 · price: Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. Read SEC document |
| June 01, 2026 Filed Jun 4, 2026 01:03 UTC |
Svoronos DawnDirector
|
Exercise / conversionRestricted Share Units · Derivative | 2,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-256118 · ownership.xml · derivative · entry 3 Svoronos Dawn · CIK 0001574579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 2,645 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. F1 · derivative.exercise_date: Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. F1 · derivative.expiration_date: Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. Read SEC document |
| June 01, 2026 Filed Jun 4, 2026 01:03 UTC |
Svoronos DawnDirector
|
Tax withholdingCommon Shares | 1,416 | $53.41 | $75,628.56 |
DisclosureSEC source: 0001193125-26-256118 · ownership.xml · nonDerivative · entry 2 Svoronos Dawn · CIK 0001574579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,229 F2 · shares: Represents the number of Common Shares withheld by the issuer to satisfy income tax withholding and remittance obligations in connection with the net settlement of the RSUs, and does not represent a sale. F3 · price: Represents the closing price of Common Shares on June 1, 2026 for purposes of net settlement calculations. Read SEC document |
| June 01, 2026 Filed Jun 4, 2026 01:03 UTC |
Svoronos DawnDirector
|
Exercise / conversionCommon Shares | 2,645 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-256118 · ownership.xml · nonDerivative · entry 1 Svoronos Dawn · CIK 0001574579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. F1 · price: Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. Read SEC document |
| June 01, 2026 Filed Jun 4, 2026 01:04 UTC |
GAROFALO ELIZABETH A.Director
|
Exercise / conversionRestricted Share Units · Derivative | 2,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-256122 · ownership.xml · derivative · entry 2 GAROFALO ELIZABETH A. · CIK 0001826361 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 2,645 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. F1 · derivative.exercise_date: Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. F1 · derivative.expiration_date: Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. Read SEC document |
| June 01, 2026 Filed Jun 4, 2026 01:04 UTC |
GAROFALO ELIZABETH A.Director
|
Exercise / conversionCommon Shares | 2,645 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-256122 · ownership.xml · nonDerivative · entry 1 GAROFALO ELIZABETH A. · CIK 0001826361 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. F1 · price: Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. Read SEC document |
| June 01, 2026 Filed Jun 4, 2026 01:03 UTC |
Cannon GillianDirector
|
Exercise / conversionRestricted Share Units · Derivative | 2,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-256120 · ownership.xml · derivative · entry 2 Cannon Gillian · CIK 0001833910 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 2,645 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. F1 · derivative.exercise_date: Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. F1 · derivative.expiration_date: Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. Read SEC document |
| June 01, 2026 Filed Jun 4, 2026 01:03 UTC |
Cannon GillianDirector
|
Exercise / conversionCommon Shares | 2,645 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-256120 · ownership.xml · nonDerivative · entry 1 Cannon Gillian · CIK 0001833910 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. F1 · price: Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. Read SEC document |
| May 12, 2026 Filed May 14, 2026 01:40 UTC |
GANNON STEVENDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,500 | $0.00 Strike: $7.38 | $0.00 |
DisclosureSEC source: 0001193125-26-222369 · ownership.xml · derivative · entry 2 GANNON STEVEN · CIK 0001643085 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 3,500 shares Expires 2026-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| May 12, 2026 Filed May 14, 2026 01:40 UTC |
GANNON STEVENDirector
|
Exercise / conversionCommon Shares | 3,500 | $7.38 | $25,830.00 |
DisclosureSEC source: 0001193125-26-222369 · ownership.xml · nonDerivative · entry 1 GANNON STEVEN · CIK 0001643085 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,641 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2026 Filed Mar 14, 2026 00:16 UTC |
KENNEY CHRISTOPHER JOHNChief Medical Officer
|
SaleCommon Shares | 1,410 | $55.23 | $77,867.25 |
DisclosureSEC source: 0001193125-26-106727 · ownership.xml · nonDerivative · entry 2 KENNEY CHRISTOPHER JOHN · CIK 0001880129 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,069 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading arrangement, in the form of a durable sell-to-cover instruction, adopted by the reporting person on December 3, 2025, solely to satisfy tax withholding obligations related to the vesting of RSUs granted on March 12, 2025. Read SEC document |
| March 13, 2026 Filed Mar 13, 2026 20:16 UTC |
DiFabio AndreaChief Legal Officer
|
SaleCommon Shares | 1,342 | $55.23 | $74,111.95 |
DisclosureSEC source: 0001193125-26-106726 · ownership.xml · nonDerivative · entry 2 DiFabio Andrea · CIK 0001692506 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,301 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading arrangement, in the form of a durable sell-to-cover instruction, adopted by the reporting person on December 3, 2025, solely to satisfy tax withholding obligations related to the vesting of RSUs granted on March 12, 2025. Read SEC document |
| March 13, 2026 Filed Mar 14, 2026 00:16 UTC |
MORTIMER IANDirector · PRESIDENT & CEO
|
SaleCommon Shares | 7,308 | $55.23 | $403,584.30 |
DisclosureSEC source: 0001193125-26-106724 · ownership.xml · nonDerivative · entry 2 MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,923 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading arrangement, in the form of a durable sell-to-cover instruction, adopted by the reporting person on December 3, 2025, solely to satisfy tax withholding obligations related to the vesting of RSUs granted on March 12, 2025. Read SEC document |
| March 12, 2026 Filed Mar 14, 2026 00:16 UTC |
KENNEY CHRISTOPHER JOHNChief Medical Officer
|
Exercise / conversionRestricted Share Units · Derivative | 3,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-106727 · ownership.xml · derivative · entry 3 KENNEY CHRISTOPHER JOHN · CIK 0001880129 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,250 Underlying: Common Shares · 3,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on March 12, 2025. The RSU award vests 25% on each of the first four anniversaries of the date of grant, beginning on March 12, 2026. F1 · derivative.exercise_date: Represents shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on March 12, 2025. The RSU award vests 25% on each of the first four anniversaries of the date of grant, beginning on March 12, 2026. F1 · derivative.expiration_date: Represents shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on March 12, 2025. The RSU award vests 25% on each of the first four anniversaries of the date of grant, beginning on March 12, 2026. Read SEC document |
| March 12, 2026 Filed Mar 14, 2026 00:16 UTC |
KENNEY CHRISTOPHER JOHNChief Medical Officer
|
Exercise / conversionCommon Shares | 3,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-106727 · ownership.xml · nonDerivative · entry 1 KENNEY CHRISTOPHER JOHN · CIK 0001880129 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,479 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on March 12, 2025. The RSU award vests 25% on each of the first four anniversaries of the date of grant, beginning on March 12, 2026. F1 · price: Represents shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on March 12, 2025. The RSU award vests 25% on each of the first four anniversaries of the date of grant, beginning on March 12, 2026. Read SEC document |
| March 12, 2026 Filed Mar 13, 2026 20:16 UTC |
DiFabio AndreaChief Legal Officer
|
Exercise / conversionRestricted Share Units · Derivative | 3,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-106726 · ownership.xml · derivative · entry 3 DiFabio Andrea · CIK 0001692506 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,250 Underlying: Common Shares · 3,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on March 12, 2025. The RSU award vests 25% on each of the first four anniversaries of the date of grant, beginning on March 12, 2026. F1 · derivative.exercise_date: Represents shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on March 12, 2025. The RSU award vests 25% on each of the first four anniversaries of the date of grant, beginning on March 12, 2026. F1 · derivative.expiration_date: Represents shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on March 12, 2025. The RSU award vests 25% on each of the first four anniversaries of the date of grant, beginning on March 12, 2026. Read SEC document |
| March 12, 2026 Filed Mar 13, 2026 20:16 UTC |
DiFabio AndreaChief Legal Officer
|
Exercise / conversionCommon Shares | 3,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-106726 · ownership.xml · nonDerivative · entry 1 DiFabio Andrea · CIK 0001692506 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,643 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on March 12, 2025. The RSU award vests 25% on each of the first four anniversaries of the date of grant, beginning on March 12, 2026. F1 · price: Represents shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on March 12, 2025. The RSU award vests 25% on each of the first four anniversaries of the date of grant, beginning on March 12, 2026. Read SEC document |
| March 12, 2026 Filed Mar 14, 2026 00:16 UTC |
MORTIMER IANDirector · PRESIDENT & CEO
|
Exercise / conversionRestricted Share Units · Derivative | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-106724 · ownership.xml · derivative · entry 4 MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Shares · 12,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on March 12, 2025. The RSU award vests 25% on each of the first four anniversaries of the date of grant, beginning on March 12, 2026. F1 · derivative.exercise_date: Represents shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on March 12, 2025. The RSU award vests 25% on each of the first four anniversaries of the date of grant, beginning on March 12, 2026. F1 · derivative.expiration_date: Represents shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on March 12, 2025. The RSU award vests 25% on each of the first four anniversaries of the date of grant, beginning on March 12, 2026. Read SEC document |
| March 12, 2026 Filed Mar 14, 2026 00:16 UTC |
MORTIMER IANDirector · PRESIDENT & CEO
|
Exercise / conversionCommon Shares | 12,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-106724 · ownership.xml · nonDerivative · entry 1 MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,231 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on March 12, 2025. The RSU award vests 25% on each of the first four anniversaries of the date of grant, beginning on March 12, 2026. F1 · price: Represents shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on March 12, 2025. The RSU award vests 25% on each of the first four anniversaries of the date of grant, beginning on March 12, 2026. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.